RME-8 regulates trafficking of the epidermal growth factor receptor

FEBS Lett. 2008 Mar 19;582(6):961-6. doi: 10.1016/j.febslet.2008.02.042. Epub 2008 Feb 26.

Abstract

We recently identified receptor-mediated endocytosis 8 (RME-8), a DnaJ domain protein localized to endosomes. We now demonstrate that RME-8 depletion leads to decreased levels of epidermal growth factor receptor (EGFR) without influencing receptors that primarily recycle to the plasma membrane. Decreases in EGFR are detected at both surface and intracellular pools and result from increased rates of EGFR degradation. Interestingly, RME-8 depletion also decreases EGFR levels in breast cancer cell lines in which overexpression of the EGFR family member ErbB2 has been shown to protect EGFR from degradation. These data implicate RME-8 in sorting decisions influencing EGFR at the level of endosomes and point to RME-8 as a potential regulatory target in ErbB2-positive breast cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms / enzymology
  • COS Cells
  • Chlorocebus aethiops
  • Endosomes / enzymology*
  • ErbB Receptors / analysis
  • ErbB Receptors / metabolism*
  • HeLa Cells
  • Humans
  • Molecular Chaperones / antagonists & inhibitors
  • Molecular Chaperones / genetics
  • Molecular Chaperones / metabolism*
  • Protein Transport
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology
  • Receptor, ErbB-2 / metabolism

Substances

  • DNAJC13 protein, human
  • Molecular Chaperones
  • RNA, Small Interfering
  • ErbB Receptors
  • Receptor, ErbB-2